Your browser doesn't support javascript.
loading
Biomarker panel increases accuracy for identification of an MS relapse beyond sNfL.
Gawde, Saurabh; Agasing, Agnieshka; Bhatt, Neal; Toliver, Mackenzie; Kumar, Gaurav; Massey, Kaylea; Nguyen, Andrew; Mao-Draayer, Yang; Macwana, Susan; DeJager, Wade; Guthridge, Joel M; Pardo, Gabriel; Dunn, Jeffrey; Axtell, Robert C.
Afiliação
  • Gawde S; Department of Arthritis and Clinical Immunology Research, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA; Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • Agasing A; Department of Arthritis and Clinical Immunology Research, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA; Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • Bhatt N; Department of Arthritis and Clinical Immunology Research, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
  • Toliver M; Department of Arthritis and Clinical Immunology Research, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
  • Kumar G; Department of Arthritis and Clinical Immunology Research, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
  • Massey K; Department of Arthritis and Clinical Immunology Research, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
  • Nguyen A; Department of Arthritis and Clinical Immunology Research, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
  • Mao-Draayer Y; Department of Neurology, Autoimmunity Center of Excellence, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Macwana S; Department of Arthritis and Clinical Immunology Research, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
  • DeJager W; Department of Arthritis and Clinical Immunology Research, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
  • Guthridge JM; Department of Arthritis and Clinical Immunology Research, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
  • Pardo G; Department of Arthritis and Clinical Immunology Research, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA; Multiple Sclerosis Center of Excellence, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.
  • Dunn J; Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.
  • Axtell RC; Department of Arthritis and Clinical Immunology Research, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA. Electronic address: bob-axtell@omrf.org.
Mult Scler Relat Disord ; 63: 103922, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35671674
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Mult Scler Relat Disord Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Mult Scler Relat Disord Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos